The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome

被引:48
作者
Belaya, Zhanna E. [1 ]
Hans, Didier [2 ]
Rozhinskaya, Liudmila Y. [1 ]
Dragunova, Natalia V. [1 ]
Sasonova, Natalia I. [1 ]
Solodovnikov, Alexander G. [3 ]
Tsoriev, Timur T. [1 ]
Dzeranova, Larisa K. [1 ]
Melnichenko, Galina A. [1 ]
Dedov, Ivan I. [1 ]
机构
[1] Natl Res Ctr Endocrinol, 11 Dmitria Uljanova Str, Moscow 117036, Russia
[2] Univ Lausanne Hosp, Ctr Bone Dis, Lausanne, Switzerland
[3] Ural State Med Univ, Ekaterinburg, Russia
关键词
Trabecular bone score; Cushing's syndrome; Fracture; Glucocorticoid-induced osteoporosis; Twenty-four-hour urinary free cortisol; VERTEBRAL FRACTURE; PRIMARY HYPERPARATHYROIDISM; OSTEOPOROTIC FRACTURES; CAUCASIAN WOMEN; MINERAL DENSITY; TBS; DIAGNOSIS; ODDS; MICROARCHITECTURE; PERFORMANCE;
D O I
10.1007/s11657-015-0244-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
.Summary In a cohort study of 182 consecutive patients with active endogenous Cushing's syndrome, the only predictor of fracture occurrence after adjustment for age, gender bone mineral density (BMD) and trabecular bone score (TBS) was 24-h urinary free cortisol (24hUFC) levels with a threshold of 1472 nmol/24 h (odds ratio, 3.00 (95 % confidence interval (CI), 1.52-5.92); p= 0.002). Introduction The aim was to estimate the risk factors for fracture in subjects with endogenous Cushing's syndrome (CS) and to evaluate the value of the TBS in these patients. Methods All enrolled patients with CS (n= 182) were interviewed in relation to low-traumatic fractures and underwent lateral X-ray imaging from T4 to L5. BMD measurements were performed using a DXA Prodigy device (GEHC Lunar, Madison, Wisconsin, USA). The TBS was derived retrospectively from existing BMD scans, blinded to clinical outcome, using TBS iNsight software v2.1 (Medimaps, Merignac, France). Urinary free cortisol (24hUFC) was measured by immunochemiluminescence assay (reference range, 60-413 nmol/24 h). Results Among enrolled patients with CS (149 females; 33 males; mean age, 37.8 years (95 % confidence interval, 34.2-39.1); 24hUFC, 2370 nmol/24 h (2087-2632), fractures were confirmed in 81 (44.5 %) patients, with 70 suffering from vertebral fractures, which were multiple in 53 cases; 24 patients reported non-vertebral fractures. The mean spine TBS was 1.207 (1.187-1.228), and TBS Z-score was -1.86 (-2.07 to -1.65); area under the curve (AUC) was used to predict fracture (mean spine TBS)= 0.548 (95 % CI, 0.454-0.641)). In the final regression model, the only predictor of fracture occurrence was 24hUFC levels (p= 0.001), with an increase of 1.041 (95 % CI, 1.019-1.063), calculated for every 100 nmol/24-h cortisol elevation (AUC (24hUFC)= 0.705 (95 % CI, 0.629-0.782)). Conclusions Young patients with CS have a low TBS. However, the only predictor of low traumatic fracture is the severity of the disease itself, indicated by high 24hUFC levels.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 39 条
[1]   Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome [J].
Belaya, Z. E. ;
Rozhinskaya, L. Y. ;
Melnichenko, G. A. ;
Solodovnikov, A. G. ;
Dragunova, N. V. ;
Iljin, A. V. ;
Dzeranova, L. K. ;
Dedov, I. I. .
OSTEOPOROSIS INTERNATIONAL, 2013, 24 (08) :2191-2199
[2]  
Belaya ZE, 2013, SERIES ENDOCRINOLOGY
[3]   Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome [J].
Belaya, Zhanna E. ;
Iljin, Alexander V. ;
Melnichenko, Galina A. ;
Rozhinskaya, Liudmila Y. ;
Dragunova, Natalia V. ;
Dzeranova, Larisa K. ;
Butrova, Svetlana A. ;
Troshina, Ekaterina A. ;
Dedov, Ivan I. .
ENDOCRINE, 2012, 41 (03) :494-500
[4]   Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement [J].
Biller, B. M. K. ;
Grossman, A. B. ;
Stewart, P. M. ;
Melmed, S. ;
Bertagna, X. ;
Bertherat, J. ;
Buchfelder, M. ;
Colao, A. ;
Hermus, A. R. ;
Hofland, L. J. ;
Klibanski, A. ;
Lacroix, A. ;
Lindsay, J. R. ;
Newell-Price, J. ;
Nieman, L. K. ;
Petersenn, S. ;
Sonino, N. ;
Stalla, G. K. ;
Swearingen, B. ;
Vance, M. L. ;
Wass, J. A. H. ;
Boscaro, M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (07) :2454-2462
[5]   Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study [J].
Boutroy, S. ;
Hans, D. ;
Sornay-Rendu, E. ;
Vilayphiou, N. ;
Winzenrieth, R. ;
Chapurlat, R. .
OSTEOPOROSIS INTERNATIONAL, 2013, 24 (01) :77-85
[6]  
Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137
[7]   Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW) [J].
Diez-Perez, Adolfo ;
Hooven, Frederick H. ;
Adachi, Jonathan D. ;
Adami, Silvano ;
Anderson, Frederick A. ;
Boonen, Steven ;
Chapurlat, Roland ;
Compston, Juliet E. ;
Cooper, Cyrus ;
Delmas, Pierre ;
Greenspan, Susan L. ;
LaCroix, Andrea Z. ;
Lindsay, Robert ;
Netelenbos, J. Coen ;
Pfeilschifter, Johannes ;
Roux, Christian ;
Saag, Kenneth G. ;
Sambrook, Philip ;
Silverman, Stuart ;
Siris, Ethel S. ;
Watts, Nelson B. ;
Nika, Grigor ;
Gehlbach, Stephen H. .
BONE, 2011, 49 (03) :493-498
[8]  
Dragunova NV, 2014, END ABSTR, V35, P69, DOI [10.1530/endoabs.35.P24, DOI 10.1530/ENDOABS.35.P24]
[9]  
Dragunova NV, 2014, OSTEOPOROS INT S2, V25, P260
[10]   Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism [J].
Eller-Vainicher, Cristina ;
Filopanti, Marcello ;
Palmieri, Serena ;
Ulivieri, Fabio Massimo ;
Morelli, Valentina ;
Zhukouskaya, Volha V. ;
Cairoli, Elisa ;
Pino, Rosa ;
Naccarato, Antonella ;
Verga, Uberta ;
Scillitani, Alfredo ;
Beck-Peccoz, Paolo ;
Chiodini, Iacopo .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 169 (02) :155-162